ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1060

Perinatal Risk Factors For Systemic Lupus: A Register-Based Case-Control Study

Elizabeth V. Arkema1 and Julia F. Simard2,3, 1Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Depts of Health Research and Policy and Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose: One’s own fetal environment has been linked to future heart disease, breast cancer, and rheumatoid arthritis. Prior work showed that among older women in the US, high birthweight and preterm birth were associated with an increased risk of SLE. Risk factors were self-reported in relatively crude categories, and data were limited on other factors of interest and unavailable for younger individuals or males. In systemic sclerosis and lupus, some have investigated links between birth order and future disease. Therefore we used population-based registers to study the association between perinatal factors and lupus in the Swedish population born 1973 onwards.

Methods: Cases were identified in the National Patient Register with at least two visits with an SLE-specific discharge diagnosis (using ICD codes) and at least one SLE-discharge from a specialty department. General population controls were matched (5:1) on birth year, sex, and residential county when the case was first identified. Using the Medical Birth Register, we obtained data on the case’s mother’s health and age during pregnancy and characteristics of labor and delivery. Restricting our study population to singleton births yielded 774 cases and 3337 controls. Birthweight was reported in grams and categorized according to standard definitions. Preterm birth was defined using gestational age in weeks and categorized. Parity was included as a continuous variable and an indicator for first born. Odds ratios and 95% CIs were estimated using conditional logistic regression models. Analyses were conducted for the entire population and separately for males and females. In sensitivity analysis, birthweight and preterm status were redefined using similar definitions to previous studies.

Results: High birthweight was not a risk factor for SLE in this younger population. Results were generally similar by sex. Preterm birth (<37 weeks) was not significantly associated with future risk of SLE overall, nor when very preterm was considered separately. Recategorizing these variables as they had been analyzed in the Nurses’ Health Studies did not appreciably change the results, nor did adjustment for maternal age, smoking in early pregnancy, and maternal BMI. Being first born was associated with 20% lower odds of SLE- this was driven by the association in females (OR=0.77, 95% CI=(0.64, 0.94)). Similarly parity was associated with SLE (OR=1.12, 95% CI=(1.02, 1.23)).

Conclusion: Lower parity and being born first were associated with reduced odds of SLE. Unlike previous work, high birthweight did not appear to be a risk factor, however this may be consistent with birth cohort trends when we examined previous published works.


Disclosure:

E. V. Arkema,
None;

J. F. Simard,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perinatal-risk-factors-for-systemic-lupus-a-register-based-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology